How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?
Michael A. Proschan(National Institute of Allergy and Infectious Diseases), Richard A. Preston, Samuel S. Blumenthal(Milwaukee VA Medical Center), Valory Pavlik(Baylor College of Medicine), James F. Graumlich(Illinois College), David Gordon(Universidade Federal de Ouro Preto), Stanley S. Franklin(Framingham Heart Study), Jeffrey A. Cutler(Unknown), Charles E. Ford(The University of Texas Health Science Center at Houston), Curt D. Furberg(Wake Forest University), Michael H. Alderman(Albert Einstein College of Medicine), William C. Cushman(University of Tennessee Health Science Center), Richard S. Castaldo(Information Today (United States)), Barry R. Davis(National Institutes of Health)
Cited by 6
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
<i>Consed:</i> A Graphical Tool for Sequence Finishing
|Genome Research|1998|3.3k
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
Prevalence of Hypertension in the US Adult Population
|Hypertension|1995|3k